Key Takeaways
- Martis Capital has acquired a majority stake in Deerfield Group, enhancing its resources to support healthcare clients.
- Deerfield Group has experienced over 30% revenue growth annually since 2017 and is advancing its services with AI integration.
- Both Martis Capital and Deerfield Group emphasize a commitment to provide innovative marketing and technology solutions across the healthcare sector.
Acquisition Overview
Martis Capital has announced its acquisition of a majority equity stake in Deerfield Group, a prominent agency specializing in marketing, communications, media, and technology for the healthcare and life sciences sectors. The financial details of the transaction were not disclosed. Despite the acquisition, Deerfield Group’s founders and management team will maintain significant ownership.
Deerfield Group, located in the Philadelphia area, provides services to a wide range of clients, including pharmaceutical, biotechnology, health tech, and consumer health companies. The firm has seen robust growth, with revenue increasing by over 30% each year since 2017.
With the backing of Martis Capital, Deerfield Group aims to expand its capabilities, enhance existing services, and develop innovative technology solutions to better support its clients throughout all stages of their business lifecycle. The agency offers a comprehensive suite of services, such as insights and strategy, creative and digital marketing, omnichannel campaigns, public relations, data analytics, sales enablement, and print management. Its unique Agency of Brand model integrates these services to provide scalable marketing and communications solutions.
Martis Capital highlighted Deerfield Group’s differentiated platform that operates at the intersection of healthcare, marketing, media, communications, and technology. The agency is evolving its identity as the “Agency of Intelligence,” leveraging both human expertise and artificial intelligence to deliver more effective and strategic solutions.
Martis Capital’s investment is designed to fortify Deerfield’s strengths and support the agency in advancing analytics and AI-enabled solutions, serving a diverse array of life sciences companies from early-stage biotech organizations to established pharmaceutical corporations.
Mario Moreno, Managing Partner at Martis Capital, stated the firm recognizes Deerfield’s strong reputation and sees significant opportunities to foster growth within the biotech and pharmaceutical sectors. Meanwhile, Frank Burrell, CEO of Deerfield Group, emphasized the agency’s commitment to a client-centric approach that combines human intelligence with advanced technology, ensuring that their services remain agile and responsive to client innovations.
Martis Capital has established a solid presence in the middle-market healthcare industry, raising over $2.2 billion from institutional clients since its inception in 2011. The firm operates out of Washington, D.C., San Francisco, and Miami, and is dedicated to investing in healthcare companies across North America.
The content above is a summary. For more details, see the source article.